Becton Dickinson at a Crossroads: Diagnostics on the Fence

BD has been doing well recently, but CEO Clateo Castellini wants to do even better--doubling revenues and profits in the next five years. That puts pressure on a company known for exploiting mature product lines. BD's diagnostics business, in particular, faces the challenge of keeping up in a rapidly consolidating segment as it goes head-to-head for the first time with the industry's heavy hitters.